sefulness of three-dimensional ultrasonography in percutaneous radiofrequency ablation.

Not Applicable

Recruiting

• Conditions: iver neoplasm

• Registration Number: JPRN-UMIN000003293
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who do not agree the purpose and procedure of the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Safety. 2. The ability of visualizing the position of the electrodes.